Submitted by Anonymous (not verified) on 22 October 2026 - 15:02
Human medicines European public assessment report (EPAR): Vydura, rimegepant, Date of authorisation: 25/04/2022, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Vydura, rimegepant, Date of authorisation: 25/04/2022, Revision: 9, Status: Authorised